These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37164232)

  • 1. Patient-centric drug product development: Acceptability across patient populations - Science and evidence.
    Stegemann S; Klingmann V; Reidemeister S; Breitkreutz J
    Eur J Pharm Biopharm; 2023 Jul; 188():1-5. PubMed ID: 37164232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational and practical considerations to guide a target product profile for patient-centric drug product development with measurable patient outcomes - A proposed roadmap.
    Stegemann S; Sheehan L; Rossi A; Barrett A; Paudel A; Crean A; Ruiz F; Bresciani M; Liu F; Shariff Z; Shine M; Schmelzer C; Pense-Lheritier AM
    Eur J Pharm Biopharm; 2022 Aug; 177():81-88. PubMed ID: 35718077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient centric drug product design in modern drug delivery as an opportunity to increase safety and effectiveness.
    Stegemann S
    Expert Opin Drug Deliv; 2018 Jun; 15(6):619-627. PubMed ID: 29719161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Centric Product Development: A Summary of Select Regulatory CMC and Device Considerations.
    Algorri M; Cauchon NS; Christian T; O'Connell C; Vaidya P
    J Pharm Sci; 2023 Apr; 112(4):922-936. PubMed ID: 36739904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining Patient Centric Pharmaceutical Drug Product Design.
    Stegemann S; Ternik RL; Onder G; Khan MA; van Riet-Nales DA
    AAPS J; 2016 Sep; 18(5):1047-1055. PubMed ID: 27317470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and opportunities to include patient-centric product design in industrial medicines development to improve therapeutic goals.
    Timpe C; Stegemann S; Barrett A; Mujumdar S
    Br J Clin Pharmacol; 2020 Oct; 86(10):2020-2027. PubMed ID: 32441052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and Opportunities for Patient Centric Drug Product Design: Industry Perspectives.
    Burke MD; Keeney M; Kleinberg R; Burlage R
    Pharm Res; 2019 Apr; 36(6):85. PubMed ID: 31001717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient acceptability, safety and access: A balancing act for selecting age-appropriate oral dosage forms for paediatric and geriatric populations.
    Walsh J; Ranmal SR; Ernest TB; Liu F
    Int J Pharm; 2018 Feb; 536(2):547-562. PubMed ID: 28705619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy for the individual: Towards patient integration into the manufacturing and provision of pharmaceuticals.
    Govender R; Abrahmsén-Alami S; Larsson A; Folestad S
    Eur J Pharm Biopharm; 2020 Apr; 149():58-76. PubMed ID: 31982577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric formulation development - Challenges of today and strategies for tomorrow: Summary report from M-CERSI workshop 2019.
    Tan DCT; Khong YM; Mount S; Galella E; Mitra B; Charlton S; Kuhli M; Ternik R; Walsh J; Rajapakshe A; Thompson K; Mehrotra S; Santangelo M; Liu J; Dixit T; Schaufelberger D; Jamzad S; Klein S; Hoag SW; Wang J; Fletcher EP; Khurana M; Alexander J; Radden E; Sood R; Selen A
    Eur J Pharm Biopharm; 2021 Jul; 164():54-65. PubMed ID: 33878432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three 'D's: Design approach, dimensional printing, and drug delivery systems as promising tools in healthcare applications.
    Rahman M; Almalki WH; Alghamdi S; Alharbi KS; Khalilullah H; Habban Akhter M; Keshari AK; Sharma N; Singh T; Soni K; Hafeez A; Beg S
    Drug Discov Today; 2021 Nov; 26(11):2726-2733. PubMed ID: 34242795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution and Translational Modeling Strategies Enabling Patient-Centric Drug Product Development: the M-CERSI Workshop Summary Report.
    Abend A; Heimbach T; Cohen M; Kesisoglou F; Pepin X; Suarez-Sharp S
    AAPS J; 2018 Apr; 20(3):60. PubMed ID: 29633092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orodispersible films: Conception to quality by design.
    Gupta MS; Kumar TP; Gowda DV; Rosenholm JM
    Adv Drug Deliv Rev; 2021 Nov; 178():113983. PubMed ID: 34547323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An industrial perspective on the design and development of medicines for older patients.
    Page S; Coupe A; Barrett A
    Int J Pharm; 2016 Oct; 512(2):352-354. PubMed ID: 27001530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations.
    Liu F; Ranmal S; Batchelor HK; Orlu-Gul M; Ernest TB; Thomas IW; Flanagan T; Tuleu C
    Drugs; 2014 Oct; 74(16):1871-1889. PubMed ID: 25274536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Big Data' informed drug development: a case for acceptability.
    Desai N; Edwards AJ; Ernest TB; Tuleu C; Orlu M
    Drug Discov Today; 2021 Apr; 26(4):865-869. PubMed ID: 33358700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of active pharmaceutical ingredient solid form selection and particle engineering into drug product design.
    Ticehurst MD; Marziano I
    J Pharm Pharmacol; 2015 Jun; 67(6):782-802. PubMed ID: 25677227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing patient-centric medicines for older people: Reflections from the draft EMA paper on the pharmaceutical development of medicines for use in the older population.
    van Riet-Nales DA; Sundberg K; de Boer A; Hirschlérova B
    Br J Clin Pharmacol; 2020 Oct; 86(10):2008-2013. PubMed ID: 32830323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.